Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Return on Invested Capital [ROIC] (2021 - 2022)

Updated

Analysis

Kyntra Bio (KYNB) Return on Invested Capital [ROIC] (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.57%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 24.28%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.52%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 22.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.11%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 12.34%
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -2,425.09%
Sep 30, 2022 -435.38%
Dec 31, 2021 -98.44%
Sep 30, 2021 -66.07%
Jun 30, 2021 -64.38%
API Access

Kyntra Bio Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=KYNB&period=max&api_key=YOUR_API_KEY